Front Page News
Cure SMA Releases the Schedule for the 2015 Annual SMA Conference
Cure SMA has released the schedule for the 2015 Annual SMA Conference, which will be held in Kansas City, June 18-21. This will be the […]
Read More ›Cure SMA Announces New $140,000 Basic Research Grant to Chad Heatwole, MD, at the University of Rochester
Cure SMA has awarded a $140,000 research grant to Chad Heatwole, MD, at the University of Rochester for his project, “Development of a Clinically Relevant […]
Read More ›SMA Researcher Meeting to Host Over 100 Presentations
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for […]
Read More ›Biogen Announces NURTURE, a New Phase 2 Clinical Trial
Biogen, in collaboration with Isis Pharmaceuticals, has announced that they will soon open recruiting for NURTURE. This is a multi-center, Phase 2 clinical study evaluating […]
Read More ›Cure SMA Announces Additional $315,000 for SMA Drug Program at The California Institute of Biomedical Research
Cure SMA is pleased to announce that we have extended our spinal muscular atrophy research program with the California Institute of Biomedical Research (CALIBR) with […]
Read More ›Cure SMA Releases Updated Overview of Research Model
When Cure SMA first started funding research thirty years ago, we had to build up from virtually nothing. It’s no easy task. Drug development relies […]
Read More ›Cure SMA Hosts SMA Researcher Meeting this June
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for […]
Read More ›How Our Cure SMA Community is Raising Awareness
Spinal muscular atrophy is the number one genetic cause of death for infants, and 1 in 50 people carry the genetic mutation that causes SMA. […]
Read More ›Updates on Pharmaceutical Companies Investing in SMA Drug Development
Over the past decade, one of the most important advances in SMA drug development has been the number of pharmaceutical companies investing in treatments for […]
Read More ›Cure SMA Awards $140,000 Grant to Francesco Lotti, PhD, of Columbia University
Cure SMA has awarded a $140,000 research grant to Francesco Lotti, PhD, at Columbia University, for his project, “Role of Sumoylation in SMN Function and […]
Read More ›